-+ 0.00%
-+ 0.00%
-+ 0.00%

Hikma Pharmaceuticals forecasts 2025 revenue growth of 4% to 6% and core operating profit of $730 million to $750 million

路透·12/17/2025 10:22:19

登录查看新闻详情